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This is the fourth in a series of four articles
that highlight the changing nature of global
health institutions.
Introduction
The global health system is in a period of
rapid transition, with an upsurge of funds
and greater political recognition, a broader
range of health challenges, many new
actors, and the rules, norms and expecta-
tions that govern them in flux. The
introductory article of this series (Szleza ´k
et al. [1]) laid out some of the many
challenges facing the global health system.
Thissystemisdefinedastheconstellationof
actors (individuals and/or organizations)
‘‘whose primary purpose is to promote,
restore or maintain health [2]’’ and ‘‘the
persistent and connected sets of rules
(formal or informal), that prescribe behav-
ioral roles, constrain activity, and shape
expectation [3]’’ among these actors. The
second article (Frenk [4]) defined the key
attributes of national health systems as a
core component of the global system. The
third article (Keusch et al. [5]) analyzed the
institutional evolution of one of the system’s
most important functions—the integration
of research, development, and delivery.
This concluding article draws on the
others in the series. It also draws from a
year-long effort that included case studies,
two international workshops of scholars
and practitioners (further details at http://
www.hks.harvard.edu/centers/cid/programs/
sustsci/events/workshops/2008/institutions),
and ongoing discussions by the authors, to
summarize lessons learned and propose
future actions to strengthen the system as a
whole. The project used as a case study the
global health system’s evolving response to
malaria. Nevertheless, the workshops and
discussions that informed this analysis
drew from a broader range of cases, and
we believe lessons learned may usefully
apply beyond malaria alone. Furthermore,
while recognizing the many determinants
of health and interlinkages between health
and other issue areas such as trade and
environment [6,7], we limit our scrutiny
here to the global health system.
The project concluded that an effective
global health system must accomplish at
least five core functions: agenda-setting;
financing and resource allocation; research
and development (R&D); implementation
and delivery; and monitoring, evaluation,
and learning. We discuss here ways to
improve each of the five functional areas,
consider the implications for the role of
the World Health Organization (WHO),
and make recommendations for future
action.
Key Functions of the Global
Health System
Agenda-Setting
In the past, global agenda-setting in
health took place within the framework of
the United Nations (UN)—primarily at
WHO and the UN Childrens Fund (UNI-
CEF)—with input from national govern-
ments and a few foundations. It was
exemplified by iconic programs such as
the eradication initiatives for malaria and
smallpox in the 1950s–70s. Agenda-setting
is well captured by a ‘‘punctuated equilib-
rium’’ model, in which long periods of
relative stability in agendas are sporadically
broken by sudden bursts of high-level
attention in public and policy circles [8,9].
Agendasmayvarybecause ofcrises, suchas
natural disasters or epidemics, or from
recognition of the human and economic
costs of inaction, as withnoncommunicable
diseases [10]. History indicates that these
episodes of high attention are fleeting;
seizing these brief opportunities to produce
lasting change usually requires adapting
governance structures to accommodate
new actors and interests [11].
Our case study of malaria found that,
after undergoing a half-century of fluctu-
ating global attention, malaria re-emerged
on the global agenda in the late 1990s.
Central to its reemergence was the crea-
tion of a novel global governance struc-
ture, the Roll Back Malaria (RBM)
Partnership, launched by WHO. RBM
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including endemic country governments,
donors, civil society organizations, the
private sector, and academia.
Once an issue garners attention and
attracts many new actors and activities,
effective governance requires a process for
setting an agenda for action within the issue
area. Coordination is ultimately essential;
however, as several experienced partici-
pants in our workshops pointed out, few
organizations wish to be coordinated,
because of the costs and loss of autonomy
entailed. Thus coordination and some
degree of harmonization of multiple inde-
pendent activities are likely to emerge only
after the construction of consensus on a
widely shared set of rules, roles, and
expectations. To get to this consensus,
participants must share a clear set of goals
and perceive the process as inclusive,
transparent, technically credible, and fair.
Effective agenda-setting for action,
when achieved, can provide a framework
(albeit no guarantee) for coordination at
global and national levels. The 2008
Global Malaria Action Plan, which was
negotiated within the RBM framework,
exemplifies how global agenda-setting for
action within an issue area can be
achieved [12]. A similar institution, the
Stop TB Partnership, has also created a
coordinating framework for tuberculosis
control.
Underlying such institutional frame-
works must be scientifically valid metrics,
evidence of the problem’s importance, and
recognition that tools exist, however im-
perfect, that could improve health out-
comes. Finally, the framework requires
that the affected countries and the public,
who are ultimately co-producers of health,
be represented as key participants [4].
These partnerships, anchored by the
legitimacy of the WHO, represent creative
approaches to eliciting the broad partici-
pation necessary to construct widely ac-
cepted agendas and forge consensus at the
global level.
Financing and Resource Allocation
International financing and resource
allocation for health in developing coun-
tries have long been subject to three
fundamental questions [13]: (1) How
should the priorities of donors be balanced
with those of recipients? (2) How should
resources be allocated to different diseases
or issue areas? (3) How can sufficient
investment into health, which has tradi-
tionally been underfunded relative to
need, be ensured?
In the past, international resources for
health flowed primarily through bi-/mul-
tilateral donors and WHO with only a few
exceptions, e.g., the Rockefeller Founda-
tion. Over the past decade a variety of
actors, including philanthropists, advocacy
groups, civil society, and public and
private sector organizations, have cata-
lyzed an unprecedented increase in the
flow of international financing for health
[14]. In the case of malaria, funding has
increased tenfold [12]. The Global Fund
to Fight AIDS, Tuberculosis and Malaria
(GFATM) represents a model for enabling
some coherence in the resource allocation
process for its mandated diseases. The
GFATM balances two often-competing
objectives: providing reassurance to do-
nors by only funding projects adhering to
international ‘‘best practices,’’ and de-
manding that country applications dem-
onstrate meaningful and widespread na-
tional ownership [15]. By unifying
multiple funding streams and oversight
processes, the GFATM also tries to lighten
the burden put on national health systems
by reporting requirements and lack of
coordination among multiple donors—an
issue exacerbated by the recent increase in
players in the global health system.
While the upsurge of financing for
malaria is welcome, it also points to a
current governance gap in the overall
system: there are no clear norms for how
resources should be allocated across dif-
ferent health needs. The Global Burden of
Disease and Disease Control Priorities
Projects have provided country estimates
of years of healthy life lost to illness and
injury, identified major risks, and estimat-
ed the cost-effectiveness of interventions
[16,17]. However, widely accepted princi-
ples on how to translate these figures into
resource allocation decisions are lacking.
Major discrepancies exist between re-
sources provided for specific diseases and
their relative burden, e.g., HIV/AIDS
versus chronic diseases, and between the
burdens of disease within specific countries
and their ability to attract resources to
address them [18].
A related question is how to increase
funding levels further to meet the full
spectrum of global health needs, and how
to sustain those levels in the long run.
Especially in difficult economic times, it is
critical to ensure continuity by insulating
finance arrangements to the greatest
extent possible [19]. In all World Bank
regions, external development assistance
represents less than 3% of total health
spending, with the exception of sub-
Saharan Africa where it accounts for
21% [20]. However, international financ-
ing is critical for providing global public
goods and for the lowest-income countries
that rely on aid to meet basic health needs.
Financial fluctuations can be disruptive in
all countries, but for the poorest, a sudden
drop in aid can be devastating. The long-
term sustainability of financing will rest on
three elements: (1) demonstrating results;
(2) making financing arrangements more
politically acceptable by mobilizing more
resources from middle-income countries;
and (3) developing innovative financing
mechanisms that are less vulnerable to
politicized budgeting processes. One such
innovative model is UNITAID, which
purchases health products for use primar-
ily in low-income countries and is funded
through national airline taxes. Of the 29
committed UNITAID donors, three-quar-
ters are low- or middle-income countries,
emphasizing the idea that all nations—
even the poorest—can contribute to sus-
tainable global health finance [21].
Research and Development
In the past, health technologies such as
drugs, vaccines, and diagnostics were
developed primarily by and for popula-
tions in the industrialized world. Today
there is increasing evidence of contribu-
tions from the South to global health
research. Investments in human capacity
that began in the 1970s are now bearing
fruit as scientists from Africa, Asia, and
Latin America take a key role in advanc-
ing research, as in the case of malaria [5].
After a period of neglect, there is now a
resurgence of R&D aimed specifically at
developing new tools for the health needs
of developing countries. Since traditional
market incentives such as the patent
system are unlikely to generate the neces-
sary innovation, much of malaria R&D is
now taking place through public–private
product development partnerships (PDPs),
which receive significant philanthropic,
public, and private investments [22]. In
contrast to classic private-sector product
development, however, the PDPs have an
explicit objective of jointly achieving
affordability and innovation suited to
developing country contexts. PDPs are
redefining the roles of public and private
sectors and promoting new expectations
for the development of health technologies
as global public goods.
Experience with malaria offers several
lessons for R&D in other health areas.
First, investments in human capital are
essential but take many years to bear
fruit. Here the long-term commitment of
the UNICEF/UNDP/World Bank/WHO
Special Programme for Research and
Training in Tropical Diseases (TDR) and
the recent 30 million commitment from
the Wellcome Trust for research capacity
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Nevertheless, greater training in laboratory
sciences, health economics, management,
program evaluation, and implementation
research are clearly needed. Capacity-build-
ing of developing country researchers and
research organizations (e.g., universities,
public research institutes) should receive
greater emphasis and be scaled up today.
Second, considerations of access to products
should be built into R&D processes from
their inception. The WHO Global Strategy
and Plan of Action on Public Health,
Innovation and Intellectual Property, ap-
proved at the 2008 World Health Assembly
(WHA), is an important contribution to
rethinking the governance of the R&D
system, and merits the constructive engage-
ment of all concerned parties [24].
Implementation and Delivery
As the essential link between global
actors and local populations, national
health systems are a critical part of the
global health system. Health systems
must accomplish multiple challenging
tasks. These include: providing preven-
tive and primary care services; develop-
ing a health workforce; devising equita-
ble financing arrangements; regulating
the private sector; and leveraging vertical
programs (such as malaria control) to
strengthen, rather than distort, the over-
all health system (‘‘diagonalization’’ [25])
([4]).
Health system performance varies wide-
ly but the reasons for this variation remain
poorly understood. For example, Eritrea,
Ethiopia and Rwanda have reduced
malaria-related morbidity and mortality
dramatically [26,27]. Eritrea, for one,
credits the RBM strategy and community
health workers as key components of their
approach [28]. However, it is unclear why,
largely using the same strategies recom-
mended to all endemic countries, others
were less successful. Recent analyses of
health systems performance point to
leadership, community involvement, dis-
trict-level focus, use of data to set priorities
and track progress, and prioritizing equi-
table access as key factors that have
enabled significant improvements in
health outcomes in some countries
[4,29]. Even when public sector delivery
capacity is weak, some countries have still
managed to expand primary health care
coverage and improve childhood survival
by engaging the private for-profit as well
as nonprofit sectors [29]. These non-state
actors can energize national health systems
by sharing knowledge of how better to
achieve efficiency, outreach, and user
satisfaction. A comprehensive operational
and policy research agenda is needed to
understand fully which policies and prac-
tices best strengthen national health sys-
tems [30,31].
Monitoring, Evaluation, and
Learning
Reliable information on the impact of
health programs is critical to setting
priorities, measuring efficacy, and main-
taining global support for any interven-
tion. Yet the global health system current-
ly poorly manages monitoring and
evaluation (M&E). There is no consensus
on key questions regarding who should be
responsible for M&E, how it should be
carried out, how available the information
should be, and how it should be used.
National and subnational organizations
for conducting M&E and promoting
critical learning are relatively weak, and
incentives for strengthening them are
almost nonexistent.
For example, there remain enormous
gaps in knowledge about malaria. Precise
annual and seasonal malaria incidence
and mortality data, or the percentage of
children with fevers that actually have
malaria, are unavailable in most endemic
countries and districts [28,32–34]. How to
mobilize communities to make full use of
bed nets, artemisinin combination thera-
pies (ACTs), and indoor spraying remain
critical research issues. With increasing
funds being expended on programs, it is
shortsighted that so little is spent on
operational research, on learning what
works in specific contexts and how best to
engage communities to use the tools
available [35]. An essential step toward
sufficient investment in M&E is to ac-
knowledge and plan for its costs, both in
dollars and, more importantly, in the
limited time available from experienced
managers and researchers. This research is
vital, yet ironically it is too rarely funded
by major donors nor requested by imple-
menting countries.
M&E should be an integral part of all
program planning, yet it is too often an
afterthought. Furthermore, effective M&E
of programs and interventions, as well as
learning from experience, requires that
M&E efforts achieve technical credibility,
maintain legitimacy (i.e., general acceptance
of their authority), and produce knowledge
that is salient for end-users. These three
objectives often compete directly with one
another [36]. For example, there is often
tension between the goal of producing
data for internal learning and that of
monitoring by outside parties (e.g., higher-
level officials or donors). When evaluation
data are linked to funding, as in currently
favored ‘‘performance-based funding,’’ the
accuracy of the data provided may
diminish. It may be necessary to create
institutional ‘‘safe spaces’’ where failures
can be divulged to encourage genuine
learning rather than used to assign blame
for underperformance [37,38].
Similarly, at the global level, all coun-
tries provide health statistics to WHO, but
the quality and validity of these data vary
greatly. Yet WHO is a producer, reposi-
tory, and evaluator of evidence, and
simultaneously a political organization
representing 193 countries, and so it will
be particularly difficult for the organiza-
tion to meet the demands for saliency,
credibility, and legitimacy. Academic re-
searchers, who also play a critical role in
M&E, face a contrasting set of difficulties.
While they may achieve technical credi-
bility, it is more challenging to achieve
political legitimacy and ensure that the
knowledge produced is salient to end users
and policy-makers.
Several new organizations are address-
ing some of these issues. For example, the
Institute for Health Metrics and Evalua-
tion [39] and the WHO-hosted Health
Metrics Network [40], both funded in part
by the Bill & Melinda Gates Foundation,
were recently created to develop methods
to acquire, analyze and disseminate rele-
vant and reliable information on burden of
disease and global health. There are
promising models, some country-based
such as the India Program Evaluation
Network coming out of the International
Clinical Epidemiology Network (IN-
CLEN) [41] and the India network,
IndiaCLEN [42], others international,
such as the Southern-led INDEPTH
epidemiological network [43] and the
Cochrane Collaboration [44]. The chal-
lenge is not only to secure the evidence,
but also to have the political and proce-
dural legitimacy that, to date, few organi-
zations other than the UN agencies have
been chartered to provide.
The Role of WHO
Cutting across these five core functions
is the question of how changes in the
global health system redefine the role of
WHO. WHO is facing ‘‘an urgent need to
define and assert a clear and effective role
for itself, as never before’’ [45]. There are
at least three key roles that we believe only
WHO can fulfill and therefore must do
well. The first is global stewardship, i.e.
identifying needs to be met and taking a
leadership role in setting global norms.
Second is as a provider of operational
support to countries: WHO has a unique
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worldwide, which should enable it to
provide technical assistance to govern-
ments through normative guidelines and
recommendations reflecting best evidence
and practice. To retain the legitimacy to
do so, it must maintain the highest
technical and ethical standards [46]. The
third is its special role in governance: as
the major global intergovernmental health
organization, WHO has a unique conven-
ing power and mandate for decision-
making on major health-related issues. Its
governing body, the World Health Assem-
bly, with its 193 Ministers of Health,
provides WHO its singular legitimacy to
carry out these mandated roles of stew-
ardship, country support, and governance,
albeit with a high degree of bureaucrati-
zation and politicization. Yet WHO’s
regular budget resources are remarkably
limited. For the 2006–7 biennium, the
formal budget assessed on countries was
less than $1 billion (with voluntary contri-
butions the total budget was just over $3
billion); the following period, three-fourths
of the budget was allocated to the regions
[47]. This excessive budgetary decentral-
ization undermines WHO’s capacity to
deliver the global public goods demanded
of it.
Inadequate levels of core funding have
resulted in predictable consequences for
performance. For example, WHO’s ma-
laria program has experienced a number
of difficulties in recent years, and while
inadequate funding is not the only cause it
is an important one. When WHO fails to
lead, new global partnerships such as
RBM (originally created by WHO’s Di-
rector-General) have stepped in, received
external funding, and, to an extent, WHO
has been marginalized. For WHO to fulfill
the key roles for which it is uniquely
charged, it will need strong leadership,
strengthened technical expertise, and
clearer focus. The current economic crisis
provides an opportunity for WHO to
redefine and strengthen its core functions,
recognize what it cannot do well, and
delegate to or partner with other organi-
zations. If it can define its core functions
and strategic role credibly, the organiza-
tion will justify—and perhaps be more
likely to receive—the greater resources it
will need to fulfill its central global mission.
Lessons and Future Needs
Several general lessons have emerged
from our study of institutions in the global
health system.
N In the present complex global envi-
ronment no single actor can or should
set the agenda for action. Global
partnerships similar to those that have
transformed malaria and the infectious
disease agenda will be needed to
mobilize resources for other health
problems, such as chronic diseases.
An example is the new Global Alliance
on Chronic Diseases [48]. Broad-
based, participatory processes for
agenda setting, anchored by WHO’s
global political legitimacy, will be
required to define priorities, avoid
unnecessary duplication, and share
knowledge. There is clearly a tension
between WHO as an intergovernmental
organization and WHO as a partner in
multiple partnerships where it must
share power with a broader set of
nongovernmental actors including civil
society organizations, foundations,
and the private sector. Widely accept-
ed procedural principles including
transparency, broad participation, in-
tegrity of data, and equity should be
adopted to construct the consensus
necessary for effective coordination.
N Sustainability depends on strengthen-
ing national health systems, which are
the essential link between global
knowledge and best practices, and
local health needs and impact. Dis-
ease-specific international funding also
has much to contribute. But it can
distort national priorities, pull resourc-
es from less-popular programs, and
ultimately undermine the overall per-
formance of the health system [49].
Country experts are often in a better
position to set priorities than outside
consultants. Donors should allow
greater flexibility for recipient coun-
tries to direct a portion of received
funds beyond narrow programmatic
interventions to strengthening national
health systems. This will require the
development of clearly defined goals
and performance indicators for key
functions of health systems such as
service provision, research, health
worker development, and equity of
access.
N Ironically, the proliferation of global
actors threatens to weaken health
systems by placing additional reporting
burdens on already thinly stretched
health ministries [49]. By channeling
multiple funding streams into a single
source for HIV/AIDS, tuberculosis,
and malaria, the GFATM offers an
instructive example of how to distrib-
ute the resources of various donors in a
way that is sensitive to national health
systems’ priorities and constraints. As
new global health initiatives arise to
address the wave of emerging health
challenges, the global health system
should identify and adopt analogous
ways to streamline reporting and,
more generally, to minimize the
additional transaction costs put on
countries.
N Systematic investment in creating new
and improving existing M&E pro-
grams should become second nature
for all global health activities. The
global health system has two important
functions to fulfill. First, it needs to set
the tone and actively foster the idea
that M&E is crucial to global health.
Second, it needs to support the sys-
tematic exchange, coordination, and
streamlining of M&E efforts. Over
time, this investment will contribute
to building robust M&E systems and to
generating reliable, comparable data
to inform action.
N There is compelling evidence that
long-term investments in education
and training at many levels (e.g.,
national, provincial, district) can result
in large payoffs for improved health
[5,50]. The global health system
should prioritize additional invest-
ments in longer-term, multidisciplinary
education and training for leadership
in the complex public health, medical,
management, economic, education,
communications, and policy aspects
of health systems, and in the function-
ing of health systems overall.
N Finally, it will be critical to support
research that provides the evidence
and knowledge bases for prioritiza-
tion, resource allocation, and the
development and evaluation of new
tools and interventions. In particular,
operational research will be crucial
to learning how to use the tools that
are available, take them to scale, and
engage populations to become co-
producers of health rather than pas-
sive recipients of services. More
broadly, research should be promoted
to understand variation in the perfor-
mance of different national health
systems, and thus to identify system
designs that can be adapted to local
circumstances to help translate global
aspirations into meaningful impact on
people’s lives.
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